Inventor · disambiguated record
Laura Sue Grosmaire
Also filed as: GROSMAIRE LAURA S · GROSMAIRE LAURA SUE
3 granted patents·11 pending applications·141 citations·filing 1999–2019
70Inventor score
Files withAPTEVO RES & DEVELOPMENT LLC3THOMPSON PETER ARMSTRONG3XCYTE THERAPIES INC2EMERGENT PRODUCT DEV SEATTLE1GROSMAIRE LAURA S1
Top patents by PatentIndex Score
14 records- 0195US8409577B2Single chain multivalent binding proteins with effector functionTHOMPSON PETER ARMSTRONG·Filed 2007·Granted Apr 2, 2013·140 cites·17 claims
- 0274US2020354447A1Single-chain multivalent binding proteins with effector functionAPTEVO RES & DEVELOPMENT LLC·Filed 2019·Application pending·0 cites
- 0367US10307481B2CD37 immunotherapeutics and uses thereofGROSMAIRE LAURA S·Filed 2006·Granted Jun 4, 2019·1 cites·14 claims
- 0464US2009214539A1B-cell reduction using cd37-specific and cd20-specific binding moleculesTRUBION PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0563US2018118823A1Single-chain multivalent binding proteins with effector functionAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Application pending·0 cites
- 0661US2014127203A1Single-chain multivalent binding proteins effector functionTHOMPSON PETER ARMSTRONG·Filed 2013·Application pending·0 cites
- 0761US2014141022A1Single-chain multivalent binding proteins with effector functionTHOMPSON PETER ARMSTRONG·Filed 2013·Application pending·0 cites
- 0859US2004253250A1Compositions and methods for regulating lymphocyte activationXCYTE THERAPIES INC·Filed 2003·Application pending·0 cites
- 0959US2019290755A1B-cell reduction using cd37-specific and cd20-specific binding moleculesAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Application pending·0 cites
- 1056US10143748B2B-cell reduction using CD37-specific and CD20-specific binding moleculesEMERGENT PRODUCT DEV SEATTLE·Filed 2013·Granted Dec 4, 2018·0 cites·8 claims
- 1151US2005261478A1Compositions and methods for regulating lymphocyte activationXCYTE THERAPIES INC·Filed 2005·Application pending·0 cites
- 1250US2011158995A1Multi-Specific Binding Proteins Targeting B Cell DisordersRENAULT SA·Filed 2009·Application pending·0 cites
- 1348US2010330089A1Anti-cd20 therapeutic compositions and methodsWYETH CORP·Filed 2008·Application pending·0 cites
- 1428US2002155604A1Compositions and methods for regulating lymphocyte activationFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →